Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network
- Loredana Amoroso
- , Victoria Castel
- , Gianni Bisogno
- , Michela Casanova
- , Catalina Marquez-Vega
- , Julia C. Chisholm
- , François Doz
- , Lucas Moreno
- , Antonio Ruggiero
- , Nicolas U. Gerber
- , Franca Fagioli
- , Pooja Hingorani
- , Soledad G. Melcón
- , Ruta Slepetis
- , Nianhang Chen
- , Yvan Le Bruchec
- , Mathew Simcock
- , Gilles Vassal
- IRCCS Istituto Giannina Gaslini - Genova
- Hospital Universitario La Fe
- University of Padua
- IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
- Hospital Universitario Virgen del Rocio
- Royal Marsden NHS Foundation Trust
- Université de Paris
- Hospital Infantil Universitario Nino Jesus de Madrid
- University of Zurich
- Ospedale Infantile Regina Margherita
- University of Texas MD Anderson Cancer Center
- Vall d’Hebron University Hospital
- Bristol-Myers Squibb
- Institut Gustave Roussy
Risultato della ricerca: Contributo in rivista › Articolo › peer review